Skip to main content
SpringerLink
Log in

Efficacy of apraclonidine ophthalmic solution (lopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

• Background: This pilot study evaluated the acute effects of topical ocular apraclonidine 1% (Iopidine) in 10 patients with presumed silicone oil-induced secondary glaucoma (SOIG) and in 10 patients with high-pressure primary open-angle glaucoma (POAG) despite maximum tolerated medical therapy. • Methods: Intraocular pressure (TOP) measurements were carried out before and 1, 2 and 3 h after a single drop of apraclonidine. • Results: Patients with SIOG presented with a mean IOP of 30.0 ± 2.8 mmHg, which was reduced to 21.7 ± 2.9 mmHg (P<0.001) after 1 h, to 20.4 ± 2.3 mmHg (P<0.001) after 2 h and to 20.0±2.5 mmHg (P<0.001) after 3 h. In the POAG group, TOP was reduced from 25.9±1.9 mmHg before treatment to 18.9±1.4 mmHg after 1 h (P<0.001), 17.7±1.2 mmHg after 2 h (P<0.001) and 16.9±0.9 mmHg after 3 h (P<0.001). There were no significant changes in blood pressure or pulse rate. • Conclusion: This study confirmed the activity of apraclonidine as an TOP suppressant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abrams DA, Robin AL, Pollack IP (1987) The safety and efficacy of topical 1% ALO2145 (p-aminoclonidine) in normal volunteers. Arch Ophthalmol 105:1205–1207

    Google Scholar 

  2. Abrams DA, Robin AL, Crandall AS, Caldwell DR, Schnitzer DB, Pollack IP, Rader JE, Reaves TA Jr (1989) A limited comparison of apraclonidine's dose response in subjects with normal or increased intraocular pressure. Am J Ophthalmol 108:230–237

    Google Scholar 

  3. Ando F (1987) Usefulness and limit of silicone oil in the management of complicated retinal detachment. Jpn J Ophthalmol 31:138–146

    Google Scholar 

  4. Barnes GE, Riva CE, Chandler ML, DeSantis L (1993) Retinal and optic nerve head blood flow responses to apraclonidine in anesthetized cats. Invest Ophthalmol Vis Sci 34:1394

    Google Scholar 

  5. Brown RH, Stewart RH, Lynch MG, Crandall AS, Mandell AI, Wilensky JT, Schwartz AL, Gaasterland DE, deFaller JM, Higginbotham EJ (1988) ALO2145 reduces the intraocular pressure elevation after anterior segment laser surgery. Ophthalmology 95:378–384

    Google Scholar 

  6. Cardakli UF, Smythe BA, Kaufman PL (1992) Effects of chronic apraclonidine treatment on IOP in advanced glaucoma. Invest Ophthalmol Vis Sci [Suppl]33:1122

    Google Scholar 

  7. Champion R, Faulborn J, Bowald S, Erb P (1987) Peritoneal reaction to liquid silicone: an experimental study. Graefe's Arch Clin Exp Ophthalmol 225:141–145

    Google Scholar 

  8. Chandler ML, DeSantis L (1985) Studies of p-amino clonidine as a potential antiglaucoma agent (ARVO abstract). Invest Ophthalmol Vis Sci 25 [Suppl]:227

    Google Scholar 

  9. Chien CS, Homsy JJ, Gluchowski C, Tang-Liu DD-S (1990) Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. Curr Eye Res 9:1051–1059

    Google Scholar 

  10. Cibis PA, Becker B, Okun E, Canaan S (1962) The use of liquid silicone in retinal detachment surgery. Ophthalmology 68:590–599

    Google Scholar 

  11. Coleman AL, Robin AL, Pollack IP (1989) Apraclonidine hydrochloride. Ophthalmol Clin North Am 2:97–108

    Google Scholar 

  12. Coleman AL, Robin AL, Pollack IP, Rudikoff MT, Enger C, Mayer PR (1990) Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine. Arch Ophthalmol 108:1264–1267

    Google Scholar 

  13. DeCorral LR, Cohen SB, Payman GA (1987) Effect of intravitreal silicone oil on intraocular pressure. Ophthalmic Surg 18:446–449

    Google Scholar 

  14. Dimopoulos S, Heimann K (1986) Spätkomplikationen nach Silikonölinjektion. Langzeitbeobachtungen an 100 Fällen. Klin Monatsbl Augenheilkd 189:223–227

    Google Scholar 

  15. Fechner PU, Reichmann KD (eds) (1991) Medikamentöse Augentherapie: Grundlagen und Praxis. Bücherei Augenarztes 67:110–111

  16. Garcia-Morales P, Dufrane SP, Sener A, et al. (1984) Inhibitory effect of clonidine upon adenylate cyclase activity, cyclic AMP production, and insulin release in rat pancreatic islets. Biosci Rep 4:511–521

    Google Scholar 

  17. Gardner S (1990) Apraclonidine for intraocular pressure control. Ocular Ther Management 1(2):1–16

    Google Scholar 

  18. Gharagozloo NZ, Relf SJ, Brubaker RF (1988) Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochlorid (ALO 2145). Ophthalmology 95:1217–1220

    Google Scholar 

  19. Gramer E (1992) Neue Kombinationspräparate mit nur zwei Applikationen täglich als Bestandteil einer medikamentösen Drei- oder Vierkomponententherapie des Glaukoms. In: Gramer E, Kampik A (eds) Pharmakotherapie am Auge. Springer, Berlin Heidelberg New York, pp 134–157

    Google Scholar 

  20. Hill RA, Minckler DS, Lee M, Heuer DK, Baerveldt G, Martone JF (1992) Medical management of cycloplegic-inducd intraocular pressure spikes. In: Gramer E, Kampik A (eds) Pharmakotherapie am Auge. Springer, Berlin Heidelberg New York, pp 116–120

    Google Scholar 

  21. Hurvitz LM, Kaufman PL, Robin AL, Weinreb RN, Crawford K, Shaw B (1991) New developments in the drug treatment of glaucoma. Drugs 41:514–532

    Google Scholar 

  22. Jampel HD (1989) Hypotony following instillation of apraclonidine for increased intraocular pressure after trabeculoplasty. Am J Ophthalmol 108:191–192

    Google Scholar 

  23. Jampel HD, Robin AL, Quigley HA, Pollack IP (1988) Apraclonidine hydrochloride. A one-week dose-response study. Arch Ophthalmol 106:1069–1073

    Google Scholar 

  24. Kampik A, Gabel VP, Spiegel D (1984) Intraokulare Tamponade mit hochviskösem Silikonöl bei massiver proliferativer Vitreo-Retinopathie. Klin Monatsbl Augenheilkd 185:368–370

    Google Scholar 

  25. Kitazawa Y, Taniguchi T, Sgiyama K (1989) The prevention of acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy. Graefe's Arch Clin Exp Ophthalmol 227:13–16

    Google Scholar 

  26. Kitazawa Y, Taniguchi T, Sugiyama K (1989) Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd-Yag laser iridotomy. Ophthalmol Surg 20:49–52

    Google Scholar 

  27. Kitazawa Y, Sugiyama K, Taniguchi T, Juoue T (1992) Apraclonidine hydrochloride therapy for glaucoma laser surgery. In: Gramer E, Kampik A (eds) Pharmakotherapie am Auge. Springer, Berlin Heidelberg New York, pp 111–115

    Google Scholar 

  28. Kriegstein GK, Gramer E (1978) The response of ophthalmic arterial pressure to topically applied clonidine. Albrecht V Graefe's Arch Klin Exp Ophthalmol 207:1–5

    Google Scholar 

  29. Lish AJ, Camras CB, Podos SM (1992) Effect of apraclonidine on intraocular pressure in glaucoma patients receiving maximally tolerated medications. J Glaucoma 1:19–22

    Google Scholar 

  30. Lucke K, Laqua H (1990) Extreme vitreoretinal surgery. In: Lucke K, Laqua H (eds) Silicone oil in the treatment of complicated retinal detachments. Springer, Berlin Heidelberg New York, pp 3–7

    Google Scholar 

  31. Lucke K, Laqua H (1990) Postoperative complications: emulsification. In: Lucke K, Laqua H (eds) Silicone oil in the treatment of complicated retinal detachments. Springer, Berlin Heidelberg New York, pp 3–7

    Google Scholar 

  32. Lucke K, Foerster MH, Laqua H (1987) Langzeiterfahrungen mit intraokularer Silikon-Füllung. Fortschr Ophthalmol 84:96–98

    Google Scholar 

  33. Lucke K, Strobel B, Foerster M, Laqua H (1990) Sekundärglaukome nach Silikonölchirurgie. Klin Monatsbl Augenheilkd 196:205–209

    Google Scholar 

  34. Mittag TW, Tormay A (1985) Drug responses of adenylate cyclase in iris-ciliary body determined by adrenine labeling. Invest Ophthalmol Vis Sci 26:396–399

    Google Scholar 

  35. Mittag TW, Tormay A (1985) Adrenergic receptor sybtypes in rabbit iris-ciliary body membranes: classification by radioligand studies. Exp Eye Res 40:239–249

    Google Scholar 

  36. Morrison JC, Robin AL (1989) Adjunctive glaucoma therapy: a comparison of apraclonidine and dipivefrin when added to timolol maleate. Ophthalmology 96:3–7

    Google Scholar 

  37. Nathanson JA (1980) Adrenergic regulation of intraocular pressure: identification of β2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium. Proc Natl Acad Sci USA 17:7420–7422

    Google Scholar 

  38. Nguyen GH, Lloyd MA, Heuer DK, Baerveldt G, Minckler DS, Lean IS, Liggett PE (1992) Incidence and management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments. Ophthalmology 99:1520–1526

    Google Scholar 

  39. Ni C, Wang W-J, Albert DM, Schepens CL (1983) Intravitreous silicone oil injection. Histologic findings in a human eye after 12 years. Arch Ophthalmol 101:1399–1401

    Google Scholar 

  40. Nomura Y, Kawata K, Kitamura Y, Watanabe H (1987) Effects of pertussis toxin on the alpha2-adrenoceptor-inhibitory GTP binding protein-adenylate cyclase system in rat brain: pharmacological and neurochemical studies. Eur J Pharmacol 134:123–129

    Google Scholar 

  41. Nowak C, Lucke K, Laqua H (1992) Sillikonölentfernung zur Behandlung des sogenannten Emulsifikationsglaukoms. Ophthalmology 6:462–464

    Google Scholar 

  42. Pape L, Ritch R, Liebmann J, Steinberger D (1992) Long-term compassionate use of apraclonidine 0.25% for refractory glaucoma. Invest Ophthalmol Vis Sci [Suppl] 33:1247

    Google Scholar 

  43. Pfeiffer N (1992) Neue Entwicklungen der medikamentösen Glaukomtherapie. Ophthalmologe 89:1–13

    Google Scholar 

  44. Pollack EP, Brown RH, Crandall AS, Robin AL, Stewart RH, et al. (1988) Effectiveness of apraclonidine in preventing the rise in intraocular pressure following neodymium: YAG posterior capsulotomy. Ophthalmology 95:461–472

    Google Scholar 

  45. Pollack IP, Brown RH, Crandall AS, Robin AL, Stewart RH, White GL (1988) Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol 106:754–757

    Google Scholar 

  46. Rentsch FJ, Atzler P, Liesenhoff H (1977) Histologische und elektronenmikroskopische Untersuchungen an einem menschlichen Auge nach mehrjähriger intravitrealer Silikonölimplantation. Ber Dtsch Ophthalmol Ges 75:70–74

    Google Scholar 

  47. Robin AL (1988) Short-term effects of unilateral 1% apraclonidine therapy. Arch Ophthalmol 106:912–915

    Google Scholar 

  48. Robin AL (1989) The role of apraclonidine hydrochloride in laser therapy for glaucoma. Trans Ophthalmol Soc 87:729–761

    Google Scholar 

  49. Robin AL, Novack GD (1991) Alpha2 agonist in the therapy of glaucoma. In: Drance SM et al. (eds) Glaucoma: applied pharmacology in medical treatment. Williams & Wilkins, Baltimore

    Google Scholar 

  50. Robin AK, Pollack IP, deFaller JM (1987) Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy. Arch Ophthalmol 105:1208–1211

    Google Scholar 

  51. Robin AL, Pollack IP, House B, Enger C (1987) Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty. Arch Ophthalmol 105:646–650

    Google Scholar 

  52. Serdahl CL, Galustian J, Lewis RA (1989) The effects of apraclonidine on conjunctival oxygen tension. Arch Ophthalmol 107:1777–1779

    Google Scholar 

  53. Tafoya ME, Toris CB, Camras CB, Yablonski ME (1992) Effects of apraclonidine on aqueous humor dynamics in human eyes. Invest Ophthalmol Vis Sci 32:929

    Google Scholar 

  54. Unnerstall JR, Kopajtic TA, Kuhar MJ (1984) Distribution of alpha2-agonist binding sites in the rat and human nervous system: analysis of some functional anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res 319:69–101

    Google Scholar 

  55. Watzke RC (1967) Silicone retinopiesis for retinal detachment. A long-term clinical evaluation. Arch Ophthalmol 77:185–196

    Google Scholar 

  56. Weinberg RS, Payman GA, Huamonte FU (1976) Elevation of intraocular pressure after pars plana vitrectomy. Graefe's Arch Klin Exp Ophthalmol 200:157–161

    Google Scholar 

  57. Wiles SB, MacKenzie D, Ide CH (1991) Control of intraocular pressure with apraclonidine hydrochloride after cataract extraction. Am J Ophthalmol 111:184–188

    Google Scholar 

  58. Wilkerson M, Lewis RA, Shields MB (1991) Follicular conjunctivitis associated with apraclonidine. Am J Ophthalmol 111(1):105–106

    Google Scholar 

  59. Yaldo MK, Shin DH, Parrow KA, Lee SH, Lee SY (1991) Additive effect of 1% apraclonidine hydrochloride to nonselective β-blockers. Ophthalmology 98:1075–1078

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Eye Hospital, Josef-Schneider-Strasse 11, D-97080, Würzburg, Germany

    Eugen Gramer, Stefanie Busche & Anselm Kampik

  2. Alcon Laboratories Inc., 6201 South Freeway, 76134-2099, Fort Worth, TX, USA

    David Parsons

Authors
  1. Eugen Gramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefanie Busche
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anselm Kampik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Parsons
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gramer, E., Busche, S., Kampik, A. et al. Efficacy of apraclonidine ophthalmic solution (lopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma. Graefe's Arch Clin Exp Ophthalmol 233, 13–20 (1995). https://doi.org/10.1007/BF00177780

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00177780

Keywords

Search

Navigation